Technical Analysis for today's market share: Starbucks Corporation (SBUX)

Company insiders own 3.40% of the company's stock.

SBUX's executive chairman SCHULTZ HOWARD D Sell 25000 shares of the company at a price of $57.28 on 2017-11-21. State Street Corp boosted its holdings in shares of Starbucks by 2.7% during the first quarter. Brown Capital Management LLC now owns 16,297 shares of the coffee company's stock worth $952,000 after acquiring an additional 1,090 shares during the last quarter. Outstanding shares refer to a company's stock presently held by all its shareholders, counting share blocks held by institutional shareholders and restricted shares owned by the company's officers and insiders. The stock increased 14.29% or $0.001 during the last trading session, reaching $0.004. IHT Wealth Management LLC raised its position in Starbucks by 10.2% in the first quarter. The Manufacturers Life Insurance Company acquired a new position in shares of Starbucks during the third quarter valued at $127,161,000. Sharkey Howes & Javer raised its holdings in Starbucks by 8.5% during the second quarter. In other Starbucks news, Director Myron E. Ullman III sold 20,000 shares of the stock in a transaction that occurred on Wednesday, May 3rd. Insiders have sold 502,584 shares of company stock valued at $28,461,828 over the last 90 days. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The stock was sold at an average price of $53.41, for a total transaction of $1,226,614.06. Following the sale, the insider now owns 29,872,564 shares in the company, valued at approximately $1,703,632,324.92. The disclosure for this sale can be found here. The Daiwa Sb Investments Ltd holds 10,420 shares with $608,000 value, down from 107,320 last quarter.

A number of equities research analysts have recently issued reports on SBUX shares. (Rating Scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell). Morgan Stanley increased their target price on Starbucks from $62.00 to $67.00 and gave the stock an "overweight" rating in a report on Friday, November 10th. Mizuho set a $75.00 target price on Starbucks and gave the stock a "buy" rating in a report on Wednesday, November 1st. Finally, Credit Suisse Group reaffirmed a "buy" rating on shares of Starbucks in a research note on Monday, November 6th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating, twenty have assigned a buy rating and one has assigned a strong buy rating to the company's stock. The company has an average rating of "Buy" and a consensus price target of $63.26.

Shares of Starbucks Corporation (NASDAQ:SBUX) opened at $59.14 on Friday.

The Beneish model is a mathematical model that makes use of financial ratios and eight variables to identify whether a firm has manipulated its profit. The stock was trading at a distance of -9.42% from its 52-week highs and stands 11.75% away from its 52-week lows. The company has a current ratio of 1.25, a quick ratio of 0.93 and a debt-to-equity ratio of 0.72.

A number of analysts offered their Estimated Earnings analysis for Starbucks Corporation (SBUX) for the current quarter. During the same quarter in the prior year, the company earned $0.39 EPS. The firm had revenue of $5.70 billion for the quarter, compared to analysts' expectations of $5.81 billion.

Net profit margin of the company is seen at 12.90%. The firm's revenue was down.2% on a year-over-year basis.

The firm also recently announced a quarterly dividend, which was paid on Friday, December 1st. Global X Mngmt Llc holds 0.03% of its portfolio in Starbucks Corporation (NASDAQ:SBUX) for 16,663 shares.

In related news, SVP Paul Mutty sold 3,000 shares of the company's stock in a transaction dated Tuesday, November 14th.

The Dow Jones Industrial Average.DJI rose 58.46 points, or 0.24 percent, to 24,290.05, the S&P 500.SPX lost 2.78 points, or 0.11 percent, to 2,639.44 and the Nasdaq Composite.IXIC dropped 72.22 points, or 1.05 percent, to 6,775.37.

With its market cap stated above, the dividend yield for Starbucks Corporation, SBUX is 2.02%. Hbk Sorce Advisory Lc holds 0.18% in Starbucks Corporation (NASDAQ:SBUX) or 19,400 shares. If you are viewing this article on another domain, it was illegally copied and republished in violation of worldwide copyright legislation. BMO Capital Markets downgraded Starbucks Corporation (NASDAQ:SBUX) on Wednesday, August 9 to "Market Perform" rating. An M-Score more than -2.22 suggests that the company is likely to be a manipulator.

Related:

Comments

Latest news

Roy Moore accuser alters story on yearbook signing, to hold press conference
Even if this allegation sinks, however, Moore has to do deal with other on the record allegations of preying on teen girls. Roy Moore's Racist "Reds and Yellows" Remark Overshadowed His Insane Claim US Hasn't Been Great Since Slavery.

New trailer for the Doctor Who Christmas special drops
Twice Upon A Time will also feature an appearance from the "Enchanted Glass People", who steal their victims from frozen time. Instead, we see the Twelfth Doctor ( Peter Capaldi ) meeting The First Doctor, played by "The Strain" star David Bradley .

OR names former Alabama assistant Mario Cristobal head coach
After Tennessee introduced Jeremy Pruitt as its coach on Thursday, Oregon was the last big school to be looking for a head coach. Cristobal held down that post through 2016, but he flocked to OR when Taggart pitched him on a new gig in the Pacific Northwest.

California's wildfires are massive-even when seen from space
The images from the ground look like something out of a horror film. 4, a series of wildfires broke out in Southern California. NASA satellites and astronauts have been sharing images of the wildfires from space and the magnitude is staggering.

FDA debuts new clinical support software draft guide, backs off certain regulations
The FDA is encouraging development of new clinical-decision support tools with new draft guidance released Thursday. That document proposes changes to the FDA's position on medical software.

Other news